CHEST Physician
-
Study shows glucocorticoids cut mortality in community acquired pneumonia in low-income settings
Anthony O. Etyang, MBChB, MMed, MSc, PhD, said recent data bolster the evidence that steroids may be useful for severe pneumonia in high-income settings as well.
-
Hypoxic burden emerges as a key cardiovascular risk marker in pediatric OSA
Investigator Olga Mediano, PhD, said hypoxic burden may more fully capture the physiological consequences of OSA by integrating the frequency, duration, and depth of oxygen desaturation events.
-
Practice-changing updates in neurocritical care
Review practice-changing updates in neurocritical care, including the risk of pneumonia in patients with ABI who are mechanically ventilated, the use of prophylactic antibiotics, how to extubate patients with ABI, and more.
-
Get to know 2026 CHEST President Neil Freedman, MD, FCCP
Hear about what President Neil Freedman, MD, FCCP, would like to accomplish throughout the next 12 months and learn what he needs from you.
-
Meet the new Editor in Chief: Diego J. Maselli, MD, FCCP
Diego J. Maselli, MD, FCCP, is the Division Chief of Pulmonary Diseases and Critical Care Medicine and a Professor of Medicine at University of Texas Health at San Antonio.
-
AI applications in pulmonary medicine: From training clinicians to transforming diagnostics and treatment
AI applications in health care are multiplying, and AI-focused research is gaining traction across specialties, including pulmonary, critical care, and sleep medicine.
-
Data show OSA is an independent, modifiable risk factor for cerebral microbleeds
The first prospective, longitudinal study of OSA and cerebral microbleeds (CMBs) found that moderate to severe OSA more than doubles the risk for microbleeds.
-
Targeting capillary refill time identified as superior resuscitation strategy
Yuri Matusov, MD, said recent findings mark a significant step toward an individualized approach for managing septic shock.
-
Trials suggest RSV vaccine reduces hospitalization for cardiorespiratory conditions in older adults
Data from studies in the United States and Denmark add to the growing evidence that respiratory syncytial virus (RSV) vaccination is effective in older adults.
-
CMS releases updated guidance for NIPPV in patients with COPD
Understand the new CMS guidance, which comes after more than a decade of strategic advocacy efforts led by CHEST.
